Despite two recent landmark court rulings awarding damages to people who contracted hepatitis C from tainted blood products, the battle over blood is far from over.</PARAGRAPH>
<PHOTO>
<TABLE WIDTH='250' ALIGN='RIGHT' BORDER='0'>
<TR>
<TD><IMG ALT='News photo' BORDER='0' SRC='../images/photos2006/nn20060914f1a.jpg' WIDTH='250' HEIGHT='167'/></TD>
</TR>
<TR>
<TD><FONT SIZE='1'><B> An inmate donates blood in 1989 at Cummins Unit in the Arkansas prison system in this still image from
the U.S. documentary 'Factor 8.'
</B> –
KELLY DUDA
On Tuesday, 17 of the 18 plaintiffs who had sued the government, Mitsubishi Pharma Corp. and its subsidiary Benesis Corp. filed an appeal of the Fukuoka District Court decision of late August that ordered the defendants to pay a combined 168 million yen in damages to only 11 of the 18 plaintiffs.
In a time of both misinformation and too much information, quality journalism is more crucial than ever. By subscribing, you can help us get the story right.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name
in the Profile section of your subscriber account page.
Your subscription plan doesn't allow commenting. To learn more see our FAQ
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.